Vaccination of sows against Mycoplasma hyopneumoniae with Hyoresp®

被引:0
作者
Beilage, EG [1 ]
Schreiber, A [1 ]
机构
[1] Tierarztlichen Hsch Hannover, Aussenstelle Epidemiol, D-49456 Bakum, Germany
来源
DEUTSCHE TIERARZTLICHE WOCHENSCHRIFT | 2005年 / 112卷 / 07期
关键词
Mycoplasma hyopneumoniae; vaccination; sow;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to investigate the serological reactions of pregnant sows to vaccination with Hyoresp (R). Further investigations were performed in the offspring of these sows to follow the dynamics of maternal antibodies and the reaction to vaccination at different points in time. The study was conducted in three farrow-to-finish herds endemically infected with M. hyopneumoniae. A total of 30 gilts and 31 sows were vaccinated 8 and 4 weeks ante partum with Hyoresp (R) (Merial GmbH) or given phys. saline solution as a placebo. The offspring was divided into three groups receiving Hyoresp (R) at 1 and 4 or at 4 and 8 weeks of age. The control group was treated with phys. saline solution at 1 and 4 weeks of age. Before vaccination, antibodies against M. hyopneumoniae were detected in 85% of the gilts and 68% of the sows, confirming the endemic infection of the herds. Vaccination of the sows induced a significant increase in the antibody concentration in serum within four weeks and enhanced the concentration of antibodies in the colostrum. As expected, significantly enhanced levels of antibodies were also detected during the first four weeks of life of the offspring of vaccinated sows. The piglets' serological reaction to vaccination at 1 and 4 weeks of age showed marked interferences with maternal antibodies, so that a reaction could be demonstrated only at 8 weeks of age. The serological reaction of piglets vaccinated at 4 and 8 weeks of age was much stronger than that of piglets vaccinated earlier. Surprisingly, the vaccination status of the sow had no effect on the serological response of the piglets in either vaccination scheme. Maternal antibodies are known to reduce the risk of M. hyopneumoniae infections in piglets. Vaccinating the sows against M. hyopneumoniae may thus be an option for farrowing-to-finish herds with an enhanced risk for infections due to ineffective separation of different age groups, poor gilt acclimatisation or high gilt replacement rates.
引用
收藏
页码:256 / 261
页数:6
相关论文
共 50 条
  • [41] Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia
    Virginio, Veridiana Gomes
    Gonchoroski, Taylor
    Paes, Jessica Andrade
    Schuck, Desiree Cigaran
    Zaha, Arnaldo
    Ferreira, Henrique Bunselmeyer
    VACCINE, 2014, 32 (44) : 5832 - 5838
  • [42] Long-term observation of respiratory disease in a closed herd with and without vaccination against Mycoplasma hyopneumoniae (M.hyo)
    Tabeling, Robert
    Pausenberger, Astrid
    Skoeries, Olaf
    TIERAERZTLICHE UMSCHAU, 2017, 72 (06) : 226 - 230
  • [43] In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection
    Ishag, Hassan Z. A.
    Wu, Yu-zi
    Liu, Mao-jun
    Xiong, Qi-yan
    Feng, Zhi-xin
    Yang, Ruo-song
    Shao, Guo-qing
    RESEARCH IN VETERINARY SCIENCE, 2016, 106 : 93 - 96
  • [44] A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs
    Charlotte S Kristensen
    Jens Vinther
    Birgitta Svensmark
    Poul Bækbo
    Acta Veterinaria Scandinavica, 56
  • [45] Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions
    Panagiotis Tassis
    Suzanne Pel
    Dimitrios Floros
    Kim ter Haar
    Qi Cao
    Ioannis Tsakmakidis
    Vassileios Papatsiros
    Niki Ntarampa
    Ioannis Arsenakis
    Eleni D. Tzika
    Porcine Health Management, 11 (1)
  • [46] Influence of age and maternal antibodies on antibody responses of neonatal piglets vaccinated against Mycoplasma hyopneumoniae
    Hodgins, DC
    Shewen, PE
    Dewey, CE
    JOURNAL OF SWINE HEALTH AND PRODUCTION, 2004, 12 (01): : 10 - 16
  • [47] Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model
    Zhang, Huilin
    Mao, Chunxiao
    Li, Jinju
    Huang, Zilong
    Gu, Xiaoyan
    Shen, Xiangguang
    Ding, Huanzhong
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [48] Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies
    Hillen, Sonja
    von Berg, Stephan
    Koehler, Kernt
    Reinacher, Manfred
    Willems, Hermann
    Reiner, Gerald
    PREVENTIVE VETERINARY MEDICINE, 2014, 113 (04) : 580 - 588
  • [49] Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs
    Maes, Dominiek
    Boyen, Filip
    Devriendt, Bert
    Kuhnert, Peter
    Summerfield, Artur
    Haesebrouck, Freddy
    VETERINARY RESEARCH, 2021, 52 (01)
  • [50] Diagnosis of enzootic pneumonia in herds vaccinated against Mycoplasma hyopneumoniae.: Part 1:: Seroreaction in pigs to different vaccination schemes
    Beilage, EG
    Schreiber, A
    Pabst, T
    TIERAERZTLICHE PRAXIS AUSGABE GROSSTIERE NUTZTIERE, 2005, 33 (04): : 239 - 245